Sees Q3 adjusted EBITDA $34M-$42M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- Evolent Health price target raised to $16 from $14 at Truist
- Evolent Health’s Positive Outlook: Strong Q2 Performance and Promising Pipeline Growth Justify Buy Rating
- Evolent Health appoints Lim as chief clinical officer, Way as CFO
- Evolent Health news Friday ‘incrementally positive,’ says UBS
- GMS jumps after report of competing suitors, Couchbase gets bought: Morning Buzz